Condition
Major Depressive Disorder With Psychotic Features
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 3 (2)
P 4 (1)
Trial Status
Not Yet Recruiting2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07263022Phase 3Not Yet Recruiting
Cognitive Strategies in Early Psychosis 2
NCT07374588Not ApplicableNot Yet Recruiting
Impact of Medication Education on Adherence and Side Effects
NCT04324944Not ApplicableCompleted
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
NCT00955474Phase 4TerminatedPrimary
Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
NCT00056472Phase 3CompletedPrimary
Study of Pharmacotherapy of Psychotic Depression
Showing all 5 trials